Phase II study of oxaliplatin and sorafenib in advanced gastric cancer after failure of cisplatin-fluoropyrimidine-based (PF) treatment.
Rosa Gallego
No relevant relationships to disclose
Marta Martin-Richard
No relevant relationships to disclose
Carles Pericay
No relevant relationships to disclose
Jesus Garcia-Foncillas
No relevant relationships to disclose
Bernardo Queralt
No relevant relationships to disclose
Esther Casado
No relevant relationships to disclose
Jaime Feliu
No relevant relationships to disclose
Iranzazu Vega
No relevant relationships to disclose
Ignacio Juez
No relevant relationships to disclose
Laura Visa
No relevant relationships to disclose
Eugeni Saigí
No relevant relationships to disclose
Xabier Garcia-Albeniz
No relevant relationships to disclose
Agust Barnadas
No relevant relationships to disclose
Joan Maurel
No relevant relationships to disclose